Share.Market Logo

Emcure Pharmaceuticals Limited

  • Minimum Investment
    ₹13,440
  • Price Range
    ₹960 - ₹1 K
  • Issue Size
    ₹1,952.03 Cr
  • Lot Size
    14 shares

Proceeds of this IPO to be used for

Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company

General corporate purposes

Download RHP DocumentGet more in-depth details about this IPO.

Strengths & Weaknesses of Emcure Pharmaceuticals Limited

Well-placed

The company is focused on the domestic market. It has successfully grown its business to become the 13th largest pharmaceutical company, the 4th largest pharmaceutical company by market share, and the largest pharmaceutical company in the gynecology and HIV antiviral therapeutic areas

Brands building

The company has demonstrated strong capabilities and a proven track record in building brands. Eight of its brands were ranked among the 300 highest-selling brands in the Indian pharma market

Product Portfolio

The company's product portfolio in the international markets comprises a mix of specialty branded generics, injectables, and generic products. Further, sales of its iron, chiral, biotherapeutics, injectables, and photo-chemistry products are developed and manufactured in-house

outstanding legal proceedings

There are outstanding legal proceedings involving the company, its directors, promoters, subsidiaries, and group company, heritage. Failure to defend these proceedings successfully may have adverse effect on the business prospects

Intensely competitive industry

The pharmaceutical industry is intensely competitive and if the company cannot respond adequately to the increased competition, it will lose market share and its profits will decline, which will adversely affect the business

Dependent on certain therapeutic products

Certain therapeutic areas contribute to a more significant portion of the company's total revenue in India, and its business, prospects, results of operations and financial condition may be adversely affected if these products in these therapeutic areas do not perform as expected

Financials

Earnings Per Share

Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.

No Data

Balance Sheet

A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr)Y/Y Change
Total Current Assets--
Total Non-Current Assets--
Fixed assets--
Total assets--
Total Current Liabilities--
Total Non-Current Liabilities--
Total Capital Plus Liabilities--
Total Shareholder Funds--
Total Debt to Equity--

Cash Flow

The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr)Y/Y Change
Cash from Operating Activity--
Cash from Financing Activities--
Cash from Investing Activities--
Net Cash Flow--

About Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals was incorporated on April 16, 1981. The company is one of the leading Indian pharmaceutical companies, engaged in developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. It is a research and development-driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics. This diversified portfolio has enabled it to reach a range of target markets across over 70 countries, with a strong presence in India, Europe, and Canada.
  • Promoter
    Satish Ramanlal Mehta
  • Promoter
    Sunil Rajanikant Mehta

Emcure Pharmaceuticals Limited IPO FAQs

What is Emcure Pharmaceuticals Limited IPO?

down-arrow
Emcure Pharmaceuticals Limited IPO refers to the initial public offering of shares by Emcure Pharmaceuticals Limited. It is a process by which the company offers its shares to the public for the first time, allowing individuals to become shareholders.

What is the issue size of Emcure Pharmaceuticals Limited IPO?

down-arrow
For Emcure Pharmaceuticals Limited IPO the issue size is ₹1,952 Cr. The issue size is the total value of the shares offered to the public. It represents the amount the company aims to raise through the IPO.

What is the minimum investment amount for the Emcure Pharmaceuticals Limited IPO?

down-arrow
For Emcure Pharmaceuticals Limited IPO the minimum investment is ₹13,440. The minimum investment for Emcure Pharmaceuticals Limited IPO is the smallest amount an individual can invest to participate in the offering. It is usually determined by the company and regulatory requirements.

What is the lot size of Emcure Pharmaceuticals Limited IPO?

down-arrow
For Emcure Pharmaceuticals Limited IPO the lot size is 14 shares. The lot size of Emcure Pharmaceuticals Limited IPO refers to the number of shares that investors need to bid for and purchase in a single transaction. It is predetermined by the company and regulators.

How to apply for Emcure Pharmaceuticals Limited IPO on Share.Market?

down-arrow
To apply for Emcure Pharmaceuticals Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the Emcure Pharmaceuticals Limited IPO from the list and click on apply now. Place your bids or choose the Cut-off Price option. Enter your UPI ID and set up your mandate to place your application.

Can I pre-apply for Emcure Pharmaceuticals Limited IPO?

down-arrow
Yes, investors can often pre-apply for some of the IPOs. Pre-application allows individuals to express their interest in participating in the IPO before the official subscription period begins. To pre- apply for Emcure Pharmaceuticals Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the IPO from the list and click on pre-apply now. Once the IPO opens for subscription you can enter your UPI ID and set up your mandate to place your application.

How many days is the IPO application window open?

down-arrow
The IPO application window typically remains open for 3 days, starting from the date of the IPO opening. However, this duration can vary depending on the specific IPO and the regulatory requirements.

Till what time can I apply for an IPO on the last day on Share.Market?

down-arrow
You can apply for the IPO till 3 PM on the last day of application on Share.Market.

What is the allotment date of Emcure Pharmaceuticals Limited IPO?

down-arrow
For Emcure Pharmaceuticals Limited IPO the allotment date is July 8, 2024. The allotment date of Emcure Pharmaceuticals Limited IPO is the date on which shares are allocated to the successful bidders. It marks the distribution of shares to investors.

What are the open and close dates of Emcure Pharmaceuticals Limited IPO?

down-arrow
For Emcure Pharmaceuticals Limited IPO, the subscription opens on July 3, 2024 and closes on July 5, 2024. The open and close dates of an IPO indicate the period during which investors can submit their bids to participate in the offering.
Bidding Ongoing
-
Total Subscription
68.86x Oversubscribed
Trade
Bidding Ongoing
-
Total Subscription
68.86x Oversubscribed
Trade